DRANT RYAN D

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$47.66M
Insider Sells Quantity
7
Insider Sells Sum
$7.17M

Insider Activity of DRANT RYAN D

The largest purchase of all time was on 2015-06-05 and amounted to 3738318 shares of Ardelyx, Inc. for $40M.

The largest sale of all time was on 2014-08-08 and amounted to 675000 shares of Viracta Therapeutics, Inc. for $4.47M.

Biography of DRANT RYAN D

No biography is available at this moment.

2015-06-05PurchaseArdelyx, Inc.
ARDX
10 percent owner
3.74M
13.1753%
$10.70$40M+13.2%
2014-10-08PurchaseJourney Medical Corporation
DERM
10 percent owner
69,112
0.9158%
$16.00$1.11M
2014-08-29SaleViracta Therapeutics, Inc.
VIRX
10 percent owner
11,600
0.0192%
$7.51$87,070-68.09%
2014-08-28SaleViracta Therapeutics, Inc.
VIRX
10 percent owner
146,800
0.2452%
$7.87$1.15M-69.28%
2014-08-27SaleViracta Therapeutics, Inc.
VIRX
10 percent owner
108,300
0.1776%
$8.17$884,811-70.96%
2014-08-12SaleViracta Therapeutics, Inc.
VIRX
10 percent owner
35,540
0.0589%
$6.76$240,190-63.95%
2014-08-08SaleViracta Therapeutics, Inc.
VIRX
10 percent owner
675,000
1.1015%
$6.62$4.47M-63.58%
2013-08-22SaleGroupon, Inc.
GRPN
10 percent owner
6,923
0.001%
$9.94$68,815-13.83%
2013-08-15SaleGroupon, Inc.
GRPN
10 percent owner
27,595
0.0041%
$9.77$269,628-7.16%
2010-06-30PurchaseViracta Therapeutics, Inc.
VIRX
10 percent owner
23.82M
6.2843%
$0.28$6.55M-14.89%
2009-10-30PurchaseViracta Therapeutics, Inc.
VIRX
10 percent owner
333,166
–
$0$0+62.16%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.